UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$646M |
| 2 |
Automatic Data Processing
ADP
|
+$510M |
| 3 |
Baidu
BIDU
|
+$349M |
| 4 |
Tesla
TSLA
|
+$320M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$758M |
| 2 |
Shopify
SHOP
|
+$568M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$521M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Healthcare | 13.27% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Communication Services | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
1801
DELISTED
Sleep Number
SNBR
| $1.8M | ﹤0.01% |
35,479
+1,011
| +3% | +$68.6K |
|
|
CD
1802
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $1.79M | ﹤0.01% |
283,661
+12,701
| +5% | +$70.1K |
|
1803
ePlus
PLUS
$2.32B
| $1.78M | ﹤0.01% |
31,749
| – | – |
|
|
ARGO
1804
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.78M | ﹤0.01% |
43,075
+5,210
| +14% | +$250K |
|
1805
Pediatrix Medical
MD
$2.13B
| $1.78M | ﹤0.01% |
75,649
-17,378
| -19% | -$425K |
|
|
TELL
1806
DELISTED
Tellurian Inc.
TELL
| $1.77M | ﹤0.01% |
334,679
+82,601
| +33% | +$278K |
|
1807
Lindsay Corp
LNN
$1.18B
| $1.76M | ﹤0.01% |
11,226
| – | – |
|
1808
Goosehead Insurance
GSHD
$2.32B
| $1.76M | ﹤0.01% |
22,372
| – | – |
|
1809
Privia Health
PRVA
$2.82B
| $1.76M | ﹤0.01% |
+65,690
| New | +$1.55M |
|
1810
Driven Brands
DRVN
$2.04B
| $1.75M | ﹤0.01% |
66,638
+3,919
| +6% | +$113K |
|
1811
Clean Energy Fuels
CLNE
$386M
| $1.75M | ﹤0.01% |
220,074
+16,387
| +8% | +$110K |
|
1812
Cerence
CRNC
$389M
| $1.74M | ﹤0.01% |
48,298
+2,654
| +6% | +$131K |
|
|
TWO
1813
Two Harbors Investment
TWO
$1.26B
| $1.74M | ﹤0.01% |
78,477
+88
| +0.1% | +$1.91K |
|
1814
Vir Biotechnology
VIR
$1.51B
| $1.74M | ﹤0.01% |
67,480
+2,438
| +4% | +$72.3K |
|
1815
Addus HomeCare
ADUS
$2.22B
| $1.73M | ﹤0.01% |
18,590
+91
| +0.5% | +$7.32K |
|
1816
Travere Therapeutics
TVTX
$5.81B
| $1.73M | ﹤0.01% |
67,181
+3,993
| +6% | +$106K |
|
1817
Supernus Pharmaceuticals
SUPN
$2.82B
| $1.73M | ﹤0.01% |
53,565
+9,589
| +22% | +$294K |
|
1818
Capitol Federal Financial
CFFN
$1.09B
| $1.73M | ﹤0.01% |
158,958
+35,154
| +28% | +$392K |
|
|
CCXI
1819
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.73M | ﹤0.01% |
68,982
-9,576
| -12% | -$269K |
|
1820
Brinker International
EAT
$9.58B
| $1.72M | ﹤0.01% |
45,146
+1,004
| +2% | +$37.6K |
|
1821
CNA Financial
CNA
$13.9B
| $1.72M | ﹤0.01% |
35,332
-1,330
| -4% | -$61.9K |
|
1822
ESCO Technologies
ESE
$7.79B
| $1.72M | ﹤0.01% |
24,557
| – | – |
|
1823
Cal-Maine
CALM
$3.88B
| $1.72M | ﹤0.01% |
31,063
-2,386
| -7% | -$104K |
|
1824
US Physical Therapy
USPH
$1.22B
| $1.71M | ﹤0.01% |
17,229
+3,136
| +22% | +$299K |
|
|
DADA
1825
DELISTED
Dada Nexus
DADA
| $1.71M | ﹤0.01% |
187,402
-11,120
| -6% | -$108K |
|
Similar funds
UBS AM's Q1 2022 Portfolio in Review
As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Baidu worth $306M.
- UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
- UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
- UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
- UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
- UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
- UBS AM opened 60 new positions and closed 124 in Q1 2022.
- UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.
Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.